MindMed Inc. Files 8-K on Director/Officer Changes

Ticker: DFTX · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1813814

Mind Medicine (Mindmed) Inc. 8-K Filing Summary
FieldDetail
CompanyMind Medicine (Mindmed) Inc. (DFTX)
Form Type8-K
Filed DateJan 13, 2025
Risk Levelmedium
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: management-change, filing

TL;DR

MindMed filed an 8-K on Jan 10, 2025, reporting director/officer changes & compensation details.

AI Summary

On January 10, 2025, Mind Medicine (MindMed) Inc. filed an 8-K report detailing changes in its board of directors and certain officers. The filing also includes information on compensatory arrangements for its officers and other events, along with financial statements and exhibits.

Why It Matters

Changes in a company's board and executive team can signal shifts in strategy or governance, impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in leadership and executive compensation can introduce uncertainty about the company's future direction and stability.

Key Players & Entities

  • Mind Medicine (MindMed) Inc. (company) — Registrant
  • January 10, 2025 (date) — Date of earliest event reported

FAQ

What specific changes were made to the board of directors or certain officers?

The filing indicates changes in directors and certain officers, but the specific details of these changes are not provided in the provided text excerpt.

What is the nature of the compensatory arrangements for certain officers mentioned in the filing?

The filing states that compensatory arrangements of certain officers are included, but the specific details of these arrangements are not detailed in the provided text excerpt.

What other events are reported in this 8-K filing?

The filing mentions 'Other Events' as an item of information, but the specific nature of these events is not detailed in the provided text excerpt.

When was this 8-K report filed with the SEC?

The 8-K report was filed on January 13, 2025, with the earliest event reported being January 10, 2025.

What is Mind Medicine (MindMed) Inc.'s principal executive office address?

Mind Medicine (MindMed) Inc.'s principal executive office is located at One World Trade Center, Suite 8500, New York, New York 10007.

Filing Stats: 487 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-01-13 08:00:21

Filing Documents

02 Departure of Directors or Certain Officers; Election of

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 10, 2025, Mind Medicine (MindMed) Inc. (the "Company") notified Miri Halperin Wernli, the Company's Executive President, that it was terminating her employment without cause, effective February 28, 2025, as the Company centralizes its management team in the United States to enhance collaboration and alignment with its strategic goals.

01 Other Events

Item 8.01 Other Events. On January 13, 2025, the Company posted an updated corporate presentation on its website. A copy of the presentation is filed herewith as Exhibit 99.1 and is incorporated by reference in this Item 8.01.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Corporate Presentation, dated January 13, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Mind Medicine (MindeMed) Inc. Date: Janaury 13, 2025 By: /s/ Robert Barrow Name: Robert Barrow Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.